Anti-Fibrotic Drug Development Summit
Event Nov 13 - Nov 14, 2017
Location: Boston, MA, USA
In the developed world, it’s believed that almost 45% of all deaths are ultimately attributable to some type of chronic fibroproliferative disease. As such, fibrosis is currently a huge unmet clinical need.
The inaugural Anti-Fibrotic Drug Development Summit will bring together drug developers from organ-specific disease areas to share transferable science, insight and lessons learned to develop more clinically effective anti-fibrotic therapeutics.
Find out more about the agenda topics and speaker faculty here: http://bit.ly/2hjl1Io